STAT+: Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Frank Pallone (D-N.J.), the ranking member of the House Committee on Energy and Commerce, asked the Government Accountability Office in an Oct. 27 letter to review whether TrumpRx has saved Americans any money.
- White House says TrumpRx has helped Americans save $700 million since the website launched in February.
- TrumpRx does not sell or dispense drugs; it directs consumers to coupons or links for discounts.
- Trump administration failed, according to Pallone, to disclose key information needed to evaluate whether the platform provided any “meaningful financial benefit,” including details of most-favored nation agreements reached with more than two dozen drugmakers.
Why it matters: Pallone’s request puts the White House’s $700 million savings claim before a government watchdog, while key details about more than two dozen drugmaker agreements remain undisclosed. Because TrumpRx only directs consumers to coupons or discount links rather than selling or dispensing drugs, its claimed benefit depends on those outside offers.
Ask SkimNews
